Bayer//Secondary Stroke Prevention

Bayer is conducting research for a new drug in the area of secondary stroke prevention

Sign up to receive updates as they become available.

Fields marked with an (*) are required.

Declaration of consent
By submitting this form, I confirm that I am a US healthcare provider, and I agree to receive news, announcements, and information about secondary stroke prevention research (including treatment options) from Bayer U.S. Pharmaceuticals. I understand my personal information will be handled in accordance with Bayer Pharmaceuticals Privacy Statement.